| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3598970 | F | Antiproliferative activity against human TOV112D cells at 50 ug/ml after 24 hrs by BrdUrd incorporation assay | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
| 2. | ALA3598971 | F | Antiproliferative activity against human TOV112D cells at 50 ug/ml after 48 hrs by BrdUrd incorporation assay | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
| 3. | ALA3598972 | F | Antiproliferative activity against human TOV112D cells at 50 ug/ml after 72 hrs by BrdUrd incorporation assay | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
| 4. | ALA3599202 | F | Antiproliferative activity against human TOV112D cells after 24 hrs by BrdUrd incorporation assay | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
| 5. | ALA3599203 | F | Antiproliferative activity against human TOV112D cells after 48 hrs by BrdUrd incorporation assay | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
| 6. | ALA3599204 | F | Antiproliferative activity against human TOV112D cells after 72 hrs by BrdUrd incorporation assay | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
| 7. | ALA4363877 | F | Cytotoxicity against human TOV112D cells transfected with empty vector assessed as reduction in cell viability incubated for 96 hrs by MTT assay | Homo sapiens | 8 | cell-based format | Scientific Literature | ||
| 8. | ALA4363878 | F | Cytotoxicity against human TOV112D cells expressing NQO2 assessed as reduction in cell viability incubated for 96 hrs by MTT assay | Homo sapiens | 8 | cell-based format | Scientific Literature | ||
| 9. | ALA4808314 | F | Growth inhibition of human TOV112D cells harbouring p53 R175H mutant incubated for 3 days by MTS assay | Homo sapiens | 29 | cell-based format | Scientific Literature | ||
| 10. | ALA4808328 | F | Anticancer activity against human TOV112D cells harbouring p53 R175H mutant xenografted NCr nu/nu mouse assessed as tumor growth inhibition at 5 mg/kg, ip relative to control | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 11. | ALA4808329 | F | Anticancer activity against human TOV112D cells harbouring p53 R175H mutant xenografted NCr nu/nu mouse assessed as tumor growth inhibition at 5.73 mg/kg, ip relative to control | Homo sapiens | 5 | organism-based format | Scientific Literature | ||
| 12. | ALA5108603 | F | Cytotoxicity against human TOV112D cells assessed as growth inhibition at 0.1 to 2.5 uM measured upto 72 hrs by crystal violet dye assay | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 13. | ALA5261969 | F | Cytotoxicity against human TOV112D cells measured after 8 days | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 14. | ALA5262697 | F | Cytotoxicity against human TOV112D cells measured after 3 days | Homo sapiens | 1 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!